Phase I, Pharmacokinetic, and Biological Study of Erlotinib in Combination With Paclitaxel and Carboplatin in Patients With Advanced Solid Tumors

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-06-1886
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)